Search results
Results from the WOW.Com Content Network
Orlistat (Xenical) and cetilistat reduce intestinal fat absorption by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested. [ 31 ]
Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity.Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake.
Blocked fat absorption. Certain weight loss drugs inhibit the absorption of dietary fats by blocking the digestive enzymes that break down fat. This reduces the number of calories you absorb overall.
Lipase inhibitors may affect the amount of fat absorbed, yet they do not block the absorption of a particular type of fat. [1] Likewise, lipase inhibitors are not absorbed into the bloodstream. Lipase inhibitors bind to lipase enzymes in the intestine, [2] thus preventing the hydrolysis of dietary triglycerides into monoglycerides and fatty ...
A daily weight loss pill from Novo Nordisk was shown to lower body weight by up to 13% after three months in a Phase 1 clinical trial, according to findings presented Tuesday at the European ...
Lipases in the gastrointestinal tract play a critical role in fat digestion. More than 95% of fat in food consists of triglycerides, which are categorized based on the length of fatty acids connected to glyceride backbone. [18] The length of long-chain triglycerides prevent their absorption through the intestinal mucosa. [19]
Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity.
The Generic Product Identifier (GPI) is a 14-character hierarchical classification system created by Wolters Kluwer's Medi-Span that identifies drugs from their primary therapeutic use down to the unique interchangeable product regardless of manufacturer or package size. The code consists of seven subsets, each providing increasingly more ...